MXPA05010659A - Formulaciones veterinarias antihelminticas topicas. - Google Patents

Formulaciones veterinarias antihelminticas topicas.

Info

Publication number
MXPA05010659A
MXPA05010659A MXPA05010659A MXPA05010659A MXPA05010659A MX PA05010659 A MXPA05010659 A MX PA05010659A MX PA05010659 A MXPA05010659 A MX PA05010659A MX PA05010659 A MXPA05010659 A MX PA05010659A MX PA05010659 A MXPA05010659 A MX PA05010659A
Authority
MX
Mexico
Prior art keywords
veterinary formulations
topical anthelmintic
topical
anthelmintic veterinary
formulations
Prior art date
Application number
MXPA05010659A
Other languages
English (en)
Inventor
Shub Natalya
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33159788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA05010659(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of MXPA05010659A publication Critical patent/MXPA05010659A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Esta invencion proporciona formulaciones antihelminticas topicas, inter alia, que comprenden una combinacion farmaceuticamente activa que consiste de por lo menos un compuesto macrociclico y por lo menos un compuesto seleccionado del grupo que consiste de prazicuantel, morantel y pirantel, que estan disueltos en un solvente o mezcla de solventes no acuosos y opcionalmente un agente de pegajosidad.
MXPA05010659A 2003-04-04 2004-04-05 Formulaciones veterinarias antihelminticas topicas. MXPA05010659A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46062703P 2003-04-04 2003-04-04
PCT/US2004/010425 WO2004089239A2 (en) 2003-04-04 2004-04-05 Topical anthelmintic veterinary formulations

Publications (1)

Publication Number Publication Date
MXPA05010659A true MXPA05010659A (es) 2005-12-12

Family

ID=33159788

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010659A MXPA05010659A (es) 2003-04-04 2004-04-05 Formulaciones veterinarias antihelminticas topicas.

Country Status (17)

Country Link
US (1) US6991801B2 (es)
EP (1) EP1610613B1 (es)
JP (1) JP2006522154A (es)
AU (2) AU2004228041B2 (es)
BR (1) BRPI0409185B1 (es)
CA (1) CA2521268C (es)
CY (1) CY1120462T1 (es)
DK (1) DK1610613T3 (es)
ES (1) ES2620413T3 (es)
HU (1) HUE032009T2 (es)
LT (1) LT1610613T (es)
MX (1) MXPA05010659A (es)
NZ (1) NZ542955A (es)
PL (1) PL1610613T3 (es)
PT (1) PT1610613T (es)
WO (1) WO2004089239A2 (es)
ZA (1) ZA200508264B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
KR100595446B1 (ko) * 2004-01-19 2006-07-03 삼성전자주식회사 디스플레이장치
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
EP1791522A1 (en) * 2004-09-16 2007-06-06 Bayer HealthCare AG Dermally applicable formulations for treating skin diseases in animals
US8293253B2 (en) * 2004-10-28 2012-10-23 Idexx Laboratories, Inc. Compositions for controlled delivery of pharmaceutically active compounds
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
EP1824474A1 (en) * 2004-12-10 2007-08-29 Bayer HealthCare AG Anthelmintic composition
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
US20060293260A1 (en) * 2005-05-24 2006-12-28 Wyeth Useful high load concentrate compositions for control of ecto-and endo-parasites
EP1931388A4 (en) * 2005-09-26 2010-12-15 Piedmont Pharmaceuticals Llc METHODS OF TREATING AND PREVENTING AVERAGE OTITIS THROUGH NON-IONIC SURFACTANTS TO FACILITATE DELIVERY OF TRANSMEMBRANE DRUG IN THE MIDDLE EAR
BRPI0616363A2 (pt) * 2005-09-26 2011-06-14 Piedmont Pharmaceuticals Llc mÉtodos para tratamento e prevenÇço de otite mÉdia usando realÇadores de penetraÇço quÍmica para facilitar a liberaÇço de fÁrmaco transmembrana para dentro do ouvido mÉdio
US8114440B2 (en) 2005-11-16 2012-02-14 Idexx Laboratories Inc. Pharmaceutical compositions for the administration of aptamers
US7754679B2 (en) 2005-11-16 2010-07-13 Idexx Laboratories, Inc. Pharmaceutical compositions for the administration of aptamers
US7700614B2 (en) * 2005-12-14 2010-04-20 Abbott Laboratories One pot synthesis of tetrazole derivatives of rapamycin
NZ548931A (en) * 2006-05-15 2008-03-28 Wyeth Corp Stabilised formulation of moxidectin
HUE052378T2 (hu) 2006-09-01 2021-04-28 Fmc Corp Lokális topikális adagolású, indoxacarb tartalmú formulációk
US8828960B2 (en) 2007-07-17 2014-09-09 Idexx Laboratories, Inc. Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
TW200924647A (en) * 2007-08-30 2009-06-16 Schering Plough Ltd Local topical administration formulations containing fipronil
FR2922108A1 (fr) 2007-10-11 2009-04-17 Virbac Sa Utilisation d'un derive de 1-n-(halo-3-pyridylmethyle)-n-methylamino-1-alkylamino -2- nitroethylene pour la preparation d'une composition pharmaceutique veterinaire pour lutter contre les puces
DK2222168T3 (en) * 2007-11-26 2018-12-03 Merial Inc SOLUTION SYSTEMS FOR POUR-ON FORMULAS TO FIGHT PARASITES
FR2925337B1 (fr) * 2007-12-21 2010-01-15 Virbac Composition pharmaceutique contenant un derive de n-phenylpyrazole et du glycofurol, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
BRPI0802255A2 (pt) * 2008-06-17 2010-03-16 Sespo Ind E Com Ltda composição de uso tópico para controle de ectoparasitos em cães e gatos
AU2010224685A1 (en) 2009-03-18 2011-11-03 Fidopharm, Inc. Parasiticidal formulation
GB0905365D0 (en) 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
US8313752B2 (en) * 2009-04-14 2012-11-20 Merial Limited Macrocyclic lactone combination compositions, vaccines and methods for producing same
EP2512467A1 (en) * 2009-12-17 2012-10-24 Merial Limited Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
AU2015202084B2 (en) * 2010-04-02 2016-07-28 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising multiple active agents, methods and uses thereof
UA108641C2 (uk) * 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
AU2016247183B2 (en) * 2010-04-02 2018-03-29 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising multiple active agents, methods and uses thereof
ES2908254T3 (es) * 2010-12-27 2022-04-28 Intervet Int Bv Formulación tópica localizada de isoxazolina que comprende glicofurol
CN102221293B (zh) * 2011-06-08 2013-05-08 大连理工大学 一种熔炼坩埚用涂层的制备方法
WO2013003168A1 (en) * 2011-06-27 2013-01-03 Merial Limited Novel insect-repellent coumarin derivatives, syntheses, and methods of use
HUE052594T2 (hu) 2011-09-12 2021-05-28 Boehringer Ingelheim Animal Health Usa Inc Izoxazolint tartalmazó parazita-ellenes készítmények, ezek elõállítása és alkalmazása
CA2895038C (en) * 2012-12-18 2020-11-24 Donaghys Limited Transdermal parasiticidal formulations
US8993613B2 (en) 2013-04-17 2015-03-31 The Hartz Mountain Corporation Ectoparasiticidal formulations
NZ701697A (en) 2014-03-24 2016-05-27 Donaghys Ltd Stable veterinary anthelmintic formulations
AR104691A1 (es) * 2016-05-18 2017-08-09 Labyes De Uruguay S A Composición veterinaria de imidacloprid, moxidectina y praziquantel de administración tópica cutánea (spot on) para tratamiento y prevención de las ecto y endoparasitosis que afectan a los perros
GB2552952B (en) * 2016-08-12 2020-03-04 Norbrook Lab Ltd Moxidectin topical liquid formulations
WO2019054967A2 (en) * 2017-03-15 2019-03-21 Verano Ilac Sanayi Ve Ticaret Anonim Sirketi VETERINARY COMPOSITION TO BE POURED COMPRISING EPRINOMECTIN
EP3595441B1 (en) 2017-03-17 2023-08-02 KRKA, d.d., Novo mesto Stable topical veterinary composition
EP3662040A1 (en) * 2017-08-03 2020-06-10 Universität Regensburg Fuel derived from renewable resources
CN111386112A (zh) * 2017-11-23 2020-07-07 法国诗华大药厂 用于治疗寄生虫感染的含有莫昔克丁的组合物
US11583545B2 (en) * 2018-02-08 2023-02-21 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
KR102188378B1 (ko) * 2018-11-02 2020-12-08 녹십자수의약품(주) 셀라멕틴을 포함하는 구충제 조성물
CN110835471B (zh) * 2019-11-19 2021-06-18 广州市汇合彩颜料有限公司 一种用于研磨颜料的低挥发有机溶剂制备方法
US10857151B1 (en) * 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis
CN113209012A (zh) * 2021-06-04 2021-08-06 湖南伟达科技有限公司 一种阿维菌素透皮溶液及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57139012A (en) * 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
GB2221621A (en) * 1988-08-12 1990-02-14 Merck & Co Inc Synergistic antiparasitic combinations of avermectin and pyrantel
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
BG61064B1 (bg) * 1993-08-12 1996-10-31 Илия Илиев Лекарствено средство за обезпаразитяване на животни
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
NZ272574A (en) * 1995-07-14 1999-02-25 Lilly Eli & Co Nz Ltd Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
IE80657B1 (en) 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
US6413542B1 (en) 1996-03-29 2002-07-02 Merial Direct pour-on antiparasitic skin solution and methods for treating, preventing and controlling myasis
US5958888A (en) 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
EP0959891A1 (en) * 1996-07-30 1999-12-01 Ashmont Holdings Limited Anthelmintic formulations
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
DE19654079A1 (de) * 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
US6042775A (en) 1998-01-29 2000-03-28 Tm Industrial Supply, Inc. Silver reclamation system
US6239112B1 (en) 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
ES2235931T3 (es) * 1999-08-12 2005-07-16 Eli Lilly And Company Formulaciones de espinosinas ectoparasiticidas en suspensiones acuosas.
AU7463000A (en) * 1999-09-22 2001-04-24 Ashmont Holdings Limited Sheep pour-on
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6207179B1 (en) * 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
CA2460692C (en) * 2001-09-17 2012-12-18 Eli Lilly And Company Pesticidal formulations
WO2003030653A2 (en) * 2001-10-05 2003-04-17 Rubicon Scientific Llc Animal feeds including actives and methods of using same
US7001889B2 (en) 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations

Also Published As

Publication number Publication date
EP1610613A4 (en) 2012-05-02
JP2006522154A (ja) 2006-09-28
CA2521268C (en) 2012-10-16
AU2004228041A1 (en) 2004-10-21
AU2004228041B2 (en) 2009-06-04
ZA200508264B (en) 2007-03-28
US6991801B2 (en) 2006-01-31
CA2521268A1 (en) 2004-10-21
PL1610613T3 (pl) 2017-06-30
EP1610613A2 (en) 2006-01-04
ES2620413T3 (es) 2017-06-28
US20040198676A1 (en) 2004-10-07
BRPI0409185A (pt) 2006-04-11
HUE032009T2 (en) 2017-09-28
BRPI0409185B1 (pt) 2018-05-15
DK1610613T3 (en) 2017-02-27
WO2004089239A2 (en) 2004-10-21
WO2004089239A3 (en) 2004-11-25
AU2009212762A1 (en) 2009-09-17
PT1610613T (pt) 2017-03-07
NZ542955A (en) 2008-07-31
LT1610613T (lt) 2017-03-27
EP1610613B1 (en) 2016-12-28
CY1120462T1 (el) 2019-07-10

Similar Documents

Publication Publication Date Title
MXPA05010659A (es) Formulaciones veterinarias antihelminticas topicas.
WO2004064769A3 (en) Methods for making and using topical delivery agents
WO2004093795A3 (en) Compositions for delivery of drug combinations
ECSP055528A (es) Composicion farmaceutica que tiene una distribución y potencia uniforme de farmaco
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
MY145148A (en) Pharmaceutical formulation comprising an antibiotic, a triazole and a carticosteroid
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
WO2006138735A3 (en) Gel compositions for topical administration
WO2005112633A3 (en) Compounds and compositions for delivering active agents
PT1206467E (pt) Derivados n-heterociclicos como inibidores de nos
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
WO2002002077A3 (en) Liposomal antineoplastic drugs and uses thereof
WO2007048027A3 (en) Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
WO2003028696A8 (en) Compositions for delivery of drug combinations
SG165404A1 (en) Fulvestrant formulation
WO2006072070A3 (en) Pharmaceutical formulations of gallium salts
WO2004060347A3 (en) Pharmaceutical propylene glycol solvate compositions
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
WO2005005436A3 (en) Cross-linked glycopeptide-cephalosporin antibiotics
WO2007133944A3 (en) Topical administration of acyclovir
UY27275A1 (es) Composiciones y metodos para aumentar la biodisponibilidad de agentes farmacéuticos
WO2005002592A3 (en) Stable oral compositions of azithromycin monohydrate
WO2003041656A3 (en) Soluble drug extended release system
WO2006004613A3 (en) Guanylhydrazone salts, compositions, processes of making and methods of using

Legal Events

Date Code Title Description
FG Grant or registration